Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2024-2030

Page: 147

Published Date: 18 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Point-of-care Testing (POCT) for Inflammatory market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Point-of-care Testing (POCT) for Inflammatory production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Inflammatory, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-of-care Testing (POCT) for Inflammatory that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Point-of-care Testing (POCT) for Inflammatory total production and demand, 2019-2030, (K Units)
Global Point-of-care Testing (POCT) for Inflammatory total production value, 2019-2030, (USD Million)
Global Point-of-care Testing (POCT) for Inflammatory production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Point-of-care Testing (POCT) for Inflammatory domestic production, consumption, key domestic manufacturers and share
Global Point-of-care Testing (POCT) for Inflammatory production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Point-of-care Testing (POCT) for Inflammatory market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens Healthineers, BioMerieux, Bio-Rad Laboratories, Assure Tech, Guangzhou Wondfo Biotech Co.,Ltd., Wuhan Easy Diagnosis and Getein Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-of-care Testing (POCT) for Inflammatory market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Point-of-care Testing (POCT) for Inflammatory Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Point-of-care Testing (POCT) for Inflammatory Market, Segmentation by Type
    Based on Immunochromatography
    Based on Chemiluminescence
    Based on Microfluidic Chip

Global Point-of-care Testing (POCT) for Inflammatory Market, Segmentation by Application
    C-Reactive Protein (CRP) Test
    Procalcitonin (PCT) Test
    Interleukin 6 (IL-6) Test
    Serum amyloid A (SAA) Test
    Others

Companies Profiled:
    Roche
    Abbott
    Siemens Healthineers
    BioMerieux
    Bio-Rad Laboratories
    Assure Tech
    Guangzhou Wondfo Biotech Co.,Ltd.
    Wuhan Easy Diagnosis
    Getein Biotech
    Beijing Hotgen Biotech Co.,ltd.
    Shanghai Upper Bio-Tech Pharma Co.,Ltd.
    Qingdao Hightop Biotech Co., Ltd.
    Goldsite Diagnostics Inc.
    Genrui Biotech Inc
    Hipro Biotechnology CO.,LTD

Key Questions Answered
1. How big is the global Point-of-care Testing (POCT) for Inflammatory market?
2. What is the demand of the global Point-of-care Testing (POCT) for Inflammatory market?
3. What is the year over year growth of the global Point-of-care Testing (POCT) for Inflammatory market?
4. What is the production and production value of the global Point-of-care Testing (POCT) for Inflammatory market?
5. Who are the key producers in the global Point-of-care Testing (POCT) for Inflammatory market?

Table of Contents

1 Supply Summary
    1.1 Point-of-care Testing (POCT) for Inflammatory Introduction
    1.2 World Point-of-care Testing (POCT) for Inflammatory Supply & Forecast
        1.2.1 World Point-of-care Testing (POCT) for Inflammatory Production Value (2019 & 2023 & 2030)
        1.2.2 World Point-of-care Testing (POCT) for Inflammatory Production (2019-2030)
        1.2.3 World Point-of-care Testing (POCT) for Inflammatory Pricing Trends (2019-2030)
    1.3 World Point-of-care Testing (POCT) for Inflammatory Production by Region (Based on Production Site)
        1.3.1 World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2019-2030)
        1.3.2 World Point-of-care Testing (POCT) for Inflammatory Production by Region (2019-2030)
        1.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2019-2030)
        1.3.4 North America Point-of-care Testing (POCT) for Inflammatory Production (2019-2030)
        1.3.5 Europe Point-of-care Testing (POCT) for Inflammatory Production (2019-2030)
        1.3.6 China Point-of-care Testing (POCT) for Inflammatory Production (2019-2030)
        1.3.7 Japan Point-of-care Testing (POCT) for Inflammatory Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Point-of-care Testing (POCT) for Inflammatory Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Point-of-care Testing (POCT) for Inflammatory Major Market Trends

2 Demand Summary
    2.1 World Point-of-care Testing (POCT) for Inflammatory Demand (2019-2030)
    2.2 World Point-of-care Testing (POCT) for Inflammatory Consumption by Region
        2.2.1 World Point-of-care Testing (POCT) for Inflammatory Consumption by Region (2019-2024)
        2.2.2 World Point-of-care Testing (POCT) for Inflammatory Consumption Forecast by Region (2025-2030)
    2.3 United States Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030)
    2.4 China Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030)
    2.5 Europe Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030)
    2.6 Japan Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030)
    2.7 South Korea Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030)
    2.8 ASEAN Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030)
    2.9 India Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030)

3 World Point-of-care Testing (POCT) for Inflammatory Manufacturers Competitive Analysis
    3.1 World Point-of-care Testing (POCT) for Inflammatory Production Value by Manufacturer (2019-2024)
    3.2 World Point-of-care Testing (POCT) for Inflammatory Production by Manufacturer (2019-2024)
    3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2019-2024)
    3.4 Point-of-care Testing (POCT) for Inflammatory Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Point-of-care Testing (POCT) for Inflammatory Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Inflammatory in 2023
        3.5.3 Global Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Inflammatory in 2023
    3.6 Point-of-care Testing (POCT) for Inflammatory Market: Overall Company Footprint Analysis
        3.6.1 Point-of-care Testing (POCT) for Inflammatory Market: Region Footprint
        3.6.2 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
        3.6.3 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Comparison
        4.1.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Comparison
        4.2.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Comparison
        4.3.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2019-2024)
    4.5 China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share
        4.5.1 China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2019-2024)
        4.5.3 China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2019-2024)
    4.6 Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2019-2024)

5 Market Analysis by Type
    5.1 World Point-of-care Testing (POCT) for Inflammatory Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Based on Immunochromatography
        5.2.2 Based on Chemiluminescence
        5.2.3 Based on Microfluidic Chip
    5.3 Market Segment by Type
        5.3.1 World Point-of-care Testing (POCT) for Inflammatory Production by Type (2019-2030)
        5.3.2 World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2019-2030)
        5.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Point-of-care Testing (POCT) for Inflammatory Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 C-Reactive Protein (CRP) Test
        6.2.2 Procalcitonin (PCT) Test
        6.2.3 Interleukin 6 (IL-6) Test
        6.2.4 Serum amyloid A (SAA) Test
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Point-of-care Testing (POCT) for Inflammatory Production by Application (2019-2030)
        6.3.2 World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2019-2030)
        6.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.1.4 Roche Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Abbott
        7.2.1 Abbott Details
        7.2.2 Abbott Major Business
        7.2.3 Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.2.4 Abbott Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Abbott Recent Developments/Updates
        7.2.6 Abbott Competitive Strengths & Weaknesses
    7.3 Siemens Healthineers
        7.3.1 Siemens Healthineers Details
        7.3.2 Siemens Healthineers Major Business
        7.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Siemens Healthineers Recent Developments/Updates
        7.3.6 Siemens Healthineers Competitive Strengths & Weaknesses
    7.4 BioMerieux
        7.4.1 BioMerieux Details
        7.4.2 BioMerieux Major Business
        7.4.3 BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.4.4 BioMerieux Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 BioMerieux Recent Developments/Updates
        7.4.6 BioMerieux Competitive Strengths & Weaknesses
    7.5 Bio-Rad Laboratories
        7.5.1 Bio-Rad Laboratories Details
        7.5.2 Bio-Rad Laboratories Major Business
        7.5.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.5.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Bio-Rad Laboratories Recent Developments/Updates
        7.5.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
    7.6 Assure Tech
        7.6.1 Assure Tech Details
        7.6.2 Assure Tech Major Business
        7.6.3 Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.6.4 Assure Tech Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Assure Tech Recent Developments/Updates
        7.6.6 Assure Tech Competitive Strengths & Weaknesses
    7.7 Guangzhou Wondfo Biotech Co.,Ltd.
        7.7.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
        7.7.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
        7.7.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.7.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
        7.7.6 Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
    7.8 Wuhan Easy Diagnosis
        7.8.1 Wuhan Easy Diagnosis Details
        7.8.2 Wuhan Easy Diagnosis Major Business
        7.8.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.8.4 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Wuhan Easy Diagnosis Recent Developments/Updates
        7.8.6 Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
    7.9 Getein Biotech
        7.9.1 Getein Biotech Details
        7.9.2 Getein Biotech Major Business
        7.9.3 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.9.4 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Getein Biotech Recent Developments/Updates
        7.9.6 Getein Biotech Competitive Strengths & Weaknesses
    7.10 Beijing Hotgen Biotech Co.,ltd.
        7.10.1 Beijing Hotgen Biotech Co.,ltd. Details
        7.10.2 Beijing Hotgen Biotech Co.,ltd. Major Business
        7.10.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.10.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
        7.10.6 Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
    7.11 Shanghai Upper Bio-Tech Pharma Co.,Ltd.
        7.11.1 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Details
        7.11.2 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
        7.11.3 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.11.4 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
        7.11.6 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Competitive Strengths & Weaknesses
    7.12 Qingdao Hightop Biotech Co., Ltd.
        7.12.1 Qingdao Hightop Biotech Co., Ltd. Details
        7.12.2 Qingdao Hightop Biotech Co., Ltd. Major Business
        7.12.3 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.12.4 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
        7.12.6 Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
    7.13 Goldsite Diagnostics Inc.
        7.13.1 Goldsite Diagnostics Inc. Details
        7.13.2 Goldsite Diagnostics Inc. Major Business
        7.13.3 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.13.4 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Goldsite Diagnostics Inc. Recent Developments/Updates
        7.13.6 Goldsite Diagnostics Inc. Competitive Strengths & Weaknesses
    7.14 Genrui Biotech Inc
        7.14.1 Genrui Biotech Inc Details
        7.14.2 Genrui Biotech Inc Major Business
        7.14.3 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.14.4 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Genrui Biotech Inc Recent Developments/Updates
        7.14.6 Genrui Biotech Inc Competitive Strengths & Weaknesses
    7.15 Hipro Biotechnology CO.,LTD
        7.15.1 Hipro Biotechnology CO.,LTD Details
        7.15.2 Hipro Biotechnology CO.,LTD Major Business
        7.15.3 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
        7.15.4 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Hipro Biotechnology CO.,LTD Recent Developments/Updates
        7.15.6 Hipro Biotechnology CO.,LTD Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Point-of-care Testing (POCT) for Inflammatory Industry Chain
    8.2 Point-of-care Testing (POCT) for Inflammatory Upstream Analysis
        8.2.1 Point-of-care Testing (POCT) for Inflammatory Core Raw Materials
        8.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Inflammatory Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Point-of-care Testing (POCT) for Inflammatory Production Mode
    8.6 Point-of-care Testing (POCT) for Inflammatory Procurement Model
    8.7 Point-of-care Testing (POCT) for Inflammatory Industry Sales Model and Sales Channels
        8.7.1 Point-of-care Testing (POCT) for Inflammatory Sales Model
        8.7.2 Point-of-care Testing (POCT) for Inflammatory Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2019-2024)
    Table 5. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2025-2030)
    Table 6. World Point-of-care Testing (POCT) for Inflammatory Production by Region (2019-2024) & (K Units)
    Table 7. World Point-of-care Testing (POCT) for Inflammatory Production by Region (2025-2030) & (K Units)
    Table 8. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2019-2024)
    Table 9. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2025-2030)
    Table 10. World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Point-of-care Testing (POCT) for Inflammatory Major Market Trends
    Table 13. World Point-of-care Testing (POCT) for Inflammatory Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Point-of-care Testing (POCT) for Inflammatory Consumption by Region (2019-2024) & (K Units)
    Table 15. World Point-of-care Testing (POCT) for Inflammatory Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Point-of-care Testing (POCT) for Inflammatory Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Point-of-care Testing (POCT) for Inflammatory Producers in 2023
    Table 18. World Point-of-care Testing (POCT) for Inflammatory Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Point-of-care Testing (POCT) for Inflammatory Producers in 2023
    Table 20. World Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Point-of-care Testing (POCT) for Inflammatory Company Evaluation Quadrant
    Table 22. World Point-of-care Testing (POCT) for Inflammatory Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Point-of-care Testing (POCT) for Inflammatory Production Site of Key Manufacturer
    Table 24. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
    Table 25. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
    Table 26. Point-of-care Testing (POCT) for Inflammatory Competitive Factors
    Table 27. Point-of-care Testing (POCT) for Inflammatory New Entrant and Capacity Expansion Plans
    Table 28. Point-of-care Testing (POCT) for Inflammatory Mergers & Acquisitions Activity
    Table 29. United States VS China Point-of-care Testing (POCT) for Inflammatory Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Point-of-care Testing (POCT) for Inflammatory Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Point-of-care Testing (POCT) for Inflammatory Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2019-2024)
    Table 37. China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2019-2024)
    Table 42. Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2019-2024)
    Table 47. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Point-of-care Testing (POCT) for Inflammatory Production by Type (2019-2024) & (K Units)
    Table 49. World Point-of-care Testing (POCT) for Inflammatory Production by Type (2025-2030) & (K Units)
    Table 50. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Point-of-care Testing (POCT) for Inflammatory Production by Application (2019-2024) & (K Units)
    Table 56. World Point-of-care Testing (POCT) for Inflammatory Production by Application (2025-2030) & (K Units)
    Table 57. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Roche Basic Information, Manufacturing Base and Competitors
    Table 62. Roche Major Business
    Table 63. Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 64. Roche Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Roche Recent Developments/Updates
    Table 66. Roche Competitive Strengths & Weaknesses
    Table 67. Abbott Basic Information, Manufacturing Base and Competitors
    Table 68. Abbott Major Business
    Table 69. Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 70. Abbott Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Abbott Recent Developments/Updates
    Table 72. Abbott Competitive Strengths & Weaknesses
    Table 73. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
    Table 74. Siemens Healthineers Major Business
    Table 75. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 76. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Siemens Healthineers Recent Developments/Updates
    Table 78. Siemens Healthineers Competitive Strengths & Weaknesses
    Table 79. BioMerieux Basic Information, Manufacturing Base and Competitors
    Table 80. BioMerieux Major Business
    Table 81. BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 82. BioMerieux Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. BioMerieux Recent Developments/Updates
    Table 84. BioMerieux Competitive Strengths & Weaknesses
    Table 85. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
    Table 86. Bio-Rad Laboratories Major Business
    Table 87. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 88. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Bio-Rad Laboratories Recent Developments/Updates
    Table 90. Bio-Rad Laboratories Competitive Strengths & Weaknesses
    Table 91. Assure Tech Basic Information, Manufacturing Base and Competitors
    Table 92. Assure Tech Major Business
    Table 93. Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 94. Assure Tech Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Assure Tech Recent Developments/Updates
    Table 96. Assure Tech Competitive Strengths & Weaknesses
    Table 97. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
    Table 98. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
    Table 99. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 100. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
    Table 102. Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
    Table 103. Wuhan Easy Diagnosis Basic Information, Manufacturing Base and Competitors
    Table 104. Wuhan Easy Diagnosis Major Business
    Table 105. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 106. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Wuhan Easy Diagnosis Recent Developments/Updates
    Table 108. Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
    Table 109. Getein Biotech Basic Information, Manufacturing Base and Competitors
    Table 110. Getein Biotech Major Business
    Table 111. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 112. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Getein Biotech Recent Developments/Updates
    Table 114. Getein Biotech Competitive Strengths & Weaknesses
    Table 115. Beijing Hotgen Biotech Co.,ltd. Basic Information, Manufacturing Base and Competitors
    Table 116. Beijing Hotgen Biotech Co.,ltd. Major Business
    Table 117. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 118. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
    Table 120. Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
    Table 121. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Basic Information, Manufacturing Base and Competitors
    Table 122. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
    Table 123. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 124. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
    Table 126. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Competitive Strengths & Weaknesses
    Table 127. Qingdao Hightop Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 128. Qingdao Hightop Biotech Co., Ltd. Major Business
    Table 129. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 130. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
    Table 132. Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
    Table 133. Goldsite Diagnostics Inc. Basic Information, Manufacturing Base and Competitors
    Table 134. Goldsite Diagnostics Inc. Major Business
    Table 135. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 136. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 137. Goldsite Diagnostics Inc. Recent Developments/Updates
    Table 138. Goldsite Diagnostics Inc. Competitive Strengths & Weaknesses
    Table 139. Genrui Biotech Inc Basic Information, Manufacturing Base and Competitors
    Table 140. Genrui Biotech Inc Major Business
    Table 141. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 142. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 143. Genrui Biotech Inc Recent Developments/Updates
    Table 144. Hipro Biotechnology CO.,LTD Basic Information, Manufacturing Base and Competitors
    Table 145. Hipro Biotechnology CO.,LTD Major Business
    Table 146. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
    Table 147. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 148. Global Key Players of Point-of-care Testing (POCT) for Inflammatory Upstream (Raw Materials)
    Table 149. Point-of-care Testing (POCT) for Inflammatory Typical Customers
    Table 150. Point-of-care Testing (POCT) for Inflammatory Typical Distributors
List of Figure
    Figure 1. Point-of-care Testing (POCT) for Inflammatory Picture
    Figure 2. World Point-of-care Testing (POCT) for Inflammatory Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Point-of-care Testing (POCT) for Inflammatory Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Point-of-care Testing (POCT) for Inflammatory Production (2019-2030) & (K Units)
    Figure 5. World Point-of-care Testing (POCT) for Inflammatory Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2019-2030)
    Figure 7. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2019-2030)
    Figure 8. North America Point-of-care Testing (POCT) for Inflammatory Production (2019-2030) & (K Units)
    Figure 9. Europe Point-of-care Testing (POCT) for Inflammatory Production (2019-2030) & (K Units)
    Figure 10. China Point-of-care Testing (POCT) for Inflammatory Production (2019-2030) & (K Units)
    Figure 11. Japan Point-of-care Testing (POCT) for Inflammatory Production (2019-2030) & (K Units)
    Figure 12. Point-of-care Testing (POCT) for Inflammatory Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 15. World Point-of-care Testing (POCT) for Inflammatory Consumption Market Share by Region (2019-2030)
    Figure 16. United States Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 17. China Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 18. Europe Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 19. Japan Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 22. India Point-of-care Testing (POCT) for Inflammatory Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Point-of-care Testing (POCT) for Inflammatory by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Inflammatory Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Inflammatory Markets in 2023
    Figure 26. United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2023
    Figure 30. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2023
    Figure 32. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Type in 2023
    Figure 34. Based on Immunochromatography
    Figure 35. Based on Chemiluminescence
    Figure 36. Based on Microfluidic Chip
    Figure 37. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Type (2019-2030)
    Figure 38. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Type (2019-2030)
    Figure 39. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2019-2030) & (US$/Unit)
    Figure 40. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Application in 2023
    Figure 42. C-Reactive Protein (CRP) Test
    Figure 43. Procalcitonin (PCT) Test
    Figure 44. Interleukin 6 (IL-6) Test
    Figure 45. Serum amyloid A (SAA) Test
    Figure 46. Others
    Figure 47. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Application (2019-2030)
    Figure 48. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Application (2019-2030)
    Figure 49. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2019-2030) & (US$/Unit)
    Figure 50. Point-of-care Testing (POCT) for Inflammatory Industry Chain
    Figure 51. Point-of-care Testing (POCT) for Inflammatory Procurement Model
    Figure 52. Point-of-care Testing (POCT) for Inflammatory Sales Model
    Figure 53. Point-of-care Testing (POCT) for Inflammatory Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Roche
Abbott
Siemens Healthineers
BioMerieux
Bio-Rad Laboratories
Assure Tech
Guangzhou Wondfo Biotech Co.,Ltd.
Wuhan Easy Diagnosis
Getein Biotech
Beijing Hotgen Biotech Co.,ltd.
Shanghai Upper Bio-Tech Pharma Co.,Ltd.
Qingdao Hightop Biotech Co., Ltd.
Goldsite Diagnostics Inc.
Genrui Biotech Inc
Hipro Biotechnology CO.,LTD

Related Reports

Global Point-of-care Testing (POCT) for Inflammatory Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Point-of-care Testing (POCT) for Inflammatory Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 28 Feb 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Inflammatory market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2023-2029

Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2023-2029

date 28 Feb 2023

date Medical Devices & Consumables

The global Point-of-care Testing (POCT) for Inflammatory market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Point-of-care Testing (POCT) for Inflammatory Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Point-of-care Testing (POCT) for Inflammatory Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Inflammatory market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Point-of-care Testing (POCT) for Inflammatory

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>